Modulari-T
We teach your immune system to attack and cure cancer
Cell and gene therapy promises to one day cure any disease; Modulari-T’s Platform produces the tools to fulfill that promise. Modulari-T has designed a new family of synthetic genes that can reprogram cells to better sense their environment and modify their behavior accordingly. This can be used to engineer immune cells to efficiently recognize and kill cancer cells or to create stem cells able to regenerate any tissue. Modulari-T looks to expand its technology to reach every area of cell therapy and become the platform of reference for cell engineering.
- Website
- modularit.bio
- City
- Montréal
- Country
- Canada
- YC batch
- Winter 2023
- Team
- 4 people
- Stage
- Early stage
- AI-native
- No
More Health & bio in Montréal
Nomic BioHiring
Nomic is doing for proteins what Illumina has done for DNA
Aescia
Canadian-Australian healthtech company building a continuous-care platform for post-discharge monitoring and specialty-clinic workflow.
Hacking Health
2012 Canadian social organization.
Claim this profile
Free and instant: prove you run modularit.bio and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Modulari-T across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Modulari-T's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
